XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders' Equity (Tables)
 9 Months Ended
Sep. 30, 2023
Stockholders' Equity Note [Abstract]  
Schedule of preferred stock dividend declaration and payment
The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2022 through September 30, 2023:

Declaration Date Record DatePayment DateDividend Per Share
August 17, 2023September 5, 2023September 29, 2023$0.46875
May 22, 2023June 5, 2023June 30, 2023$0.46875
February 21, 2023March 6, 2023March 31, 2023$0.46875
Schedule of cash dividends on its preferred stock and common stock
The following table presents cash dividends declared by the Company on its Series C Preferred Stock from January 1, 2022 through September 30, 2023:

Declaration Date Record DatePayment DateDividend Per Share
August 17, 2023September 5, 2023September 29, 2023$0.40625
May 22, 2023June 5, 2023June 30, 2023$0.40625
February 21, 2023March 6, 2023March 31, 2023$0.40625
The following table presents cash dividends declared by the Company on its common stock from January 1, 2022 through September 30, 2023:

Declaration Date
Record DatePayment DateDividend Per Share 
September 20, 2023October 2, 2023October 31, 2023$0.350(1)
June 15, 2023June 30, 2023July 31, 2023$0.350
March 10, 2023March 31, 2023April 28, 2023$0.350
(1) At September 30, 2023, the Company had accrued dividends and dividend equivalents payable of $35.8 million related to the common stock dividend declared on June 15, 2023.
Schedule of changes in balances of each component of the entity's AOCI
The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2023:
Three Months Ended
September 30, 2023		Nine Months Ended
September 30, 2023
(In Thousands)Net Unrealized
Gain/(Loss) on
AFS Securities
Net Unrealized Gain/(Loss) on Financing Agreements (1)
Total 
AOCI		Net Unrealized
Gain/(Loss) on
AFS Securities
Net Unrealized Gain/(Loss) on Financing Agreements (1)
Total 
AOCI
Balance at beginning of period$13,420 $— $13,420 $21,341 $— $21,341 
OCI before reclassifications933 — 933 (6,988)— (6,988)
Amounts reclassified from AOCI— — — — — — 
Net OCI during the period (2)
933 — 933 (6,988)— (6,988)
Balance at end of period$14,353 $— $14,353 $14,353 $— $14,353 

(1)Net Unrealized Gain/(Loss) on Financing Agreements at Fair Value due to changes in instrument-specific credit risk.
(2) For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).
 

The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2022:
Three Months Ended
September 30, 2022		Nine Months Ended
September 30, 2022
(In Thousands)Net Unrealized
Gain/(Loss) on
AFS Securities
Net Unrealized Gain/(Loss) on Financing Agreements (1)
Total
AOCI		Net Unrealized
Gain/(Loss) on
AFS Securities
Net Unrealized Gain/(Loss) on Financing Agreements (1)
Total
AOCI
Balance at beginning of period$36,919 $— $36,919 $46,833 $(1,255)$45,578 
OCI before reclassifications(5,851)— (5,851)(15,765)1,255 (14,510)
Amounts reclassified from AOCI— — — — — — 
Net OCI during the period (2)
(5,851)— (5,851)(15,765)1,255 (14,510)
Balance at end of period$31,068 $— $31,068 $31,068 $— $31,068 

(1)  Net Unrealized Gain/(Loss) on Financing Agreements at Fair Value due to changes in instrument-specific credit risk.
(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).